Clinical Trial Update: A Study of LY2951742 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study of LY2951742 (galcanezumab) in healthy volunteers conducted by Eli Lilly has completed, and results have been posted. The study is related to mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Galcanezumab (galcanezumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraines | Phase 1 | Status: COMPLETED | Results posted: 2019-02-20